Freeman Kevin Lee - Insider Non-Derivative Transactions at Health Catalyst, Inc. (HCAT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 1, 2025, Freeman Kevin Lee's relationship to Health Catalyst, Inc. (HCAT) is Officer (Chief Commercial Officer), and currently has 358,686 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other HCAT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Freeman Kevin Lee - Insider Non-Derivative Transactions of HCAT Common Stock

Freeman Kevin Lee - Insider Non-Derivative Transactions at HCAT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 2, 2025	F -- (Common Stock)	16401	2.9	358686
Sep 3, 2025	F -- (Common Stock)	4578	3.36	375087
Jun 3, 2025	F -- (Common Stock)	4747	3.63	379665
Mar 4, 2025	F -- (Common Stock)	10800	4.58	384412
Feb 21, 2025	Acquisition -- (Common Stock)	140000	0	376950
Feb 21, 2025	Acquisition -- (Common Stock)	18262	0	395212
Dec 3, 2024	Sell -- (Common Stock)	7500	8.94	236950
Dec 2, 2024	F -- (Common Stock)	11431	8.97	244450
Sep 4, 2024	Sell -- (Common Stock)	7500	7.22	255881
Sep 4, 2024	F -- (Common Stock)	2772	7.27	263381
Jun 12, 2024	Sell -- (Common Stock)	7500	6.53	266153
Jun 4, 2024	F -- (Common Stock)	2951	6.53	273653
Mar 2, 2024	F -- (Common Stock)	4540	8.05	276604
Feb 21, 2024	Acquisition -- (Common Stock)	110000	0	277810
Feb 21, 2024	Acquisition -- (Common Stock)	3334	0	281144
Dec 2, 2023	F -- (Common Stock)	2921	7.45	167810
Sep 2, 2023	F -- (Common Stock)	8460	11.78	170731
Jun 2, 2023	F -- (Common Stock)	1038	11.24	179191
Mar 2, 2023	F -- (Common Stock)	1569	14.29	177846
Mar 2, 2023	Acquisition -- (Common Stock)	1819	0	179665
Mar 2, 2023	Acquisition -- (Common Stock)	1264	0	180929